HK Stock Market Move | UNISOUND (09678) rose over 5% and officially launched its self-developed medical imaging multimodal model "U2-RadiMed".

date
14:26 13/08/2026
avatar
GMT Eight
Yunzhisheng (09678) has risen over 5%. As of the time of writing, it is up 3.89%, priced at HKD 76.15, with a transaction volume of HKD 70.8855 million.
UNISOUND (09678) rose over 5%, and as of the time of this report, had increased by 3.89%, reaching HKD 76.15, with a trading volume of HKD 70.8855 million. On August 13, UNISOUND announced that following the release of the U2-Med tri-medical model, the company has officially launched its self-developed multi-modal large model for medical imaging, "U2-RadiMed." This model is the first in the country to deeply integrate medical image understanding, report generation, clinical reasoning, and visual question answering into a full-link imaging large model. It supports both single and multiple images along with text as multi-modal mixed input, covering mainstream medical imaging types such as CXR (chest X-ray), CT, and MRI. It establishes a framework with six core capabilities: report generation, lesion detection and localization, clinical reasoning, clinical decision-making, general medical VQA, and advanced medical reasoning, allowing for a complete workflow loop from "viewing images retrieving knowledge making inferences drawing conclusions." The release of U2-RadiMed marks the official entry of the company's large model capabilities into the more complex and specialized core scenario of medical imaging, further enhancing the company's healthcare AI product system from "general foundational large modelstri-medical specialized large modelsmedical imaging multi-modal large models" and consolidating its technological leadership in the field of medical artificial intelligence. In the future, the company will continue to deepen its application and innovation of large models in the broader healthcare field, promoting the transition of medical imaging AI from technological breakthroughs to actual medical productivity, helping healthcare institutions improve quality and efficiency, and creating long-term value for shareholders.